Minapharm Pharmaceuticals (MIPH) Share Price — EGX

EGP 763+0.66%Indicator average: −0.07 (−1 to +1)

Minapharm Pharmaceuticals (MIPH) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 10:30 (Cairo time).

What is Minapharm Pharmaceuticals’s share price today? MIPH last traded at EGP 763 (+0.66% on the day), for a market value of EGP 8.40 billion and a dividend yield of 0.33%. Its 52-week range is EGP 302.22 to 1,000.

MIPH price performance

1W
+1.3%
1M
-4.7%
3M
+2.4%
6M
+16.7%
YTD
+118.4%
1Y
+135.7%
5Y
+871.8%

Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.

About Minapharm Pharmaceuticals

Minapharm Pharmaceuticals engages in the manufacture and marketing of pharmaceutical products. It offers products that specialize in gastroenterology, ophthalmology, dermatology, cardiology, biogenetics and orthopedics. The company was founded by Saad El Bardissi in 1958 and is headquartered in Cairo, Egypt.

Industry:
Pharmaceuticals: Major
Employees:
450
ISIN:
EGS380G1C011
Website:
www.minapharm.com

MIPH key statistics

Last price
EGP 763
Previous close
EGP 740
Day change
0.66%
52-week range
EGP 302.22 – 1,000
Volume
287
Shares outstanding
11.78M
Free float
42.13%
Market cap
EGP 8.4B
P/E (trailing)
1,275.92
P/B
1.43
Dividend yield (FY 2025)
0.33%
ROE
0.7%
Book value / share
EGP 530.56
Beta (1Y)
0.7
50-day MA
EGP 796.28
200-day MA
EGP 618.21
RSI (14)
45.96

Data as of 28 Oct 2026, 10:30 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).

Key terms behind the MIPH figures

Market Capitalization
Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio
The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio
The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield
Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is Minapharm Pharmaceuticals (MIPH) share price today?
Minapharm Pharmaceuticals last traded at EGP 763 on the Egyptian Exchange (as of 28 Oct 2026, 10:30, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is MIPH's market capitalization?
Minapharm Pharmaceuticals has a market capitalization of about EGP 8.4B.
Does MIPH pay dividends?
Yes — Minapharm Pharmaceuticals paid EGP 2.5 per share for fiscal 2025, a dividend yield of 0.33% at the last price.
What is MIPH's P/E ratio?
Minapharm Pharmaceuticals trades at a trailing price-to-earnings ratio of 1,275.92.
What sector is Minapharm Pharmaceuticals in?
Minapharm Pharmaceuticals is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.
Where can I track MIPH?
This Starta Markets page shows Minapharm Pharmaceuticals's EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.